Kim Theresa W, Bernstein Judith, Cheng Debbie M, Lloyd-Travaglini Christine, Samet Jeffrey H, Palfai Tibor P, Saitz Richard
Section of General Internal Medicine, Boston Medical Center, Clinical Addiction Research and Education (CARE) Unit, Boston University School of Medicine, Boston, MA, USA.
Department of Biostatistics (DMC), Data Coordinating Center (CLT), Department of Community Health Sciences, Boston University School Public Health, Boston, MA, USA.
Addiction. 2017 May;112(5):818-827. doi: 10.1111/add.13701. Epub 2017 Feb 7.
Screening, brief intervention and 'referral to treatment' programs have been promoted widely as US federal policy. Little is known about the efficacy of the RT component (referral to treatment) of brief intervention for motivating patients with unhealthy drug use identified by screening to use addiction treatment. This study aimed to compare receipt of addiction treatment following two types of brief intervention for drug use versus a no-intervention control group among primary care patients screening positive for drug use.
Secondary analyses from a single-site randomized controlled trial.
Massachusetts, USA.
A total of 528 adults with Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) drug-specific scores ≥ 4.
Random assignment to: (1) a 10-15-minute brief negotiated interview (BNI) conducted by health educators (n = 174), (2) a 30-45-minute adaptation of motivational interviewing by Masters-level counselors (MOTIV) (n = 177) or (3) no BI (n = 177). All received a list of treatment and mutual help resources; both intervention protocols included dedicated staff for treatment referrals.
Receipt of any addiction treatment within 6 months after study entry, assessed in a state-wide database and hospital electronic medical record linked to trial data.
Among 528 participants, the main drugs used were marijuana (63%), cocaine (19%) and opioids (17%); 46% met past-year drug dependence criteria (short form Composite International Diagnostic Interview); and 10% of MOTIV, 18% of BNI and 17% of control participants had any addiction treatment receipt within 6 months after study entry. There was no significant difference in addiction treatment receipt for BNI versus control [adjusted odds ratio (AOR) = 1.11; 95% confidence interval (CI) = 0.57, 2.15, Hochberg adjusted P = 0.76]. The MOTIV group had lower odds of linking to treatment (AOR = 0.36, 95% CI = 0.17, 0.78, Hochberg adjusted P = 0.02) compared with the no BI group.
Brief intervention delivered in primary care for screen-identified drug use did not increase addiction treatment receipt significantly; a motivational interviewing approach appeared to be counterproductive.
作为美国联邦政策,筛查、简短干预和“转介治疗”项目已得到广泛推广。关于简短干预中的转介治疗(RT)部分在促使经筛查发现有不健康药物使用行为的患者接受成瘾治疗方面的效果,人们了解甚少。本研究旨在比较在初级保健患者中,针对药物使用的两种类型的简短干预与无干预对照组相比,在筛查出药物使用呈阳性的患者中,接受成瘾治疗的情况。
来自单中心随机对照试验的二次分析。
美国马萨诸塞州。
共有528名成年人,其酒精、吸烟和物质使用筛查测试(ASSIST)特定药物得分≥4。
随机分配至:(1)由健康教育工作者进行的10 - 15分钟简短协商访谈(BNI)(n = 174),(2)由硕士水平咨询师进行的30 - 45分钟动机性访谈改编版(MOTIV)(n = 177),或(3)无简短干预(n = 177)。所有参与者都收到了一份治疗和互助资源清单;两种干预方案都包括专门负责治疗转介的工作人员。
在研究入组后6个月内接受任何成瘾治疗的情况,通过与试验数据相链接的全州数据库和医院电子病历进行评估。
在528名参与者中,主要使用的药物为大麻(63%)、可卡因(19%)和阿片类药物(17%);46%符合过去一年药物依赖标准(简易版综合国际诊断访谈);在研究入组后6个月内,MOTIV组中有10%、BNI组中有18%、对照组中有17%的参与者接受了任何成瘾治疗。BNI组与对照组在接受成瘾治疗方面无显著差异[调整后的优势比(AOR)= 1.11;95%置信区间(CI)= 0.57,2.15,霍奇伯格校正P = 0.76]。与无简短干预组相比,MOTIV组接受治疗的几率较低(AOR = 0.36,95% CI = 0.17,0.78,霍奇伯格校正P = 0.02)。
在初级保健中针对筛查出的药物使用进行的简短干预并未显著增加成瘾治疗的接受率;动机性访谈方法似乎适得其反。